Kesselheim, Aaron S.

The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform

Kesselheim, A. S., Avorn, J., & Sarpatwari, A. (2016) · JAMA

Pharmaceutical Economics and PolicyHealthcare Policy and Management

Cited by 592

Clinical Decision Support Systems Could Be Modified To Reduce ‘Alert Fatigue’ While Still Minimizing The Risk Of Litigation

Kesselheim, A. S., Cresswell, K., Phansalkar, S., Bates, D. W., & Sheikh, A. (2011) · Health Affairs

Electronic Health Records SystemsMedical Malpractice and Liability Issues

Cited by 277

Mitigating bias in machine learning for medicine

Vokinger, K. N., Feuerriegel, S., & Kesselheim, A. S. (2021) · Communications Medicine

Ethics and Social Impacts of AIArtificial Intelligence in Healthcare and Education

Cited by 269

Evaluation of Aducanumab for Alzheimer Disease: Scientific Evidence and Regulatory Review Involving Efficacy, Safety, and Futility

Alexander, G. C., Emerson, S., & Kesselheim, A. S. (2021) · JAMA

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 240

A Randomized Study of How Physicians Interpret Research Funding Disclosures

Kesselheim, A. S., Robertson, C. T., Myers, J. A., Rose, S. L., Gillet, V., Ross, K. M., Glynn, R. J., Joffe, S., & Avorn, J. (2012) · New England Journal of Medicine

Pharmaceutical industry and healthcareEthics in Clinical Research

Cited by 183

Revisiting FDA Approval of Aducanumab

Alexander, G. C., Knopman, D. S., Emerson, S. S., Ovbiagele, B., Kryscio, R. J., Perlmutter, J. S., & Kesselheim, A. S. (2021) · New England Journal of Medicine

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 162

Comparative Effectiveness of Generic and Brand-Name Statins on Patient Outcomes: A Cohort Study

Gagne, J. J., Choudhry, N. K., Kesselheim, A. S., Polinski, J. M., Hutchins, D., Matlin, O. S., Brennan, T. A., Avorn, J., & Shrank, W. H. (2014) · Annals of Internal Medicine

Lipoproteins and Cardiovascular HealthMedication Adherence and Compliance

Cited by 155

Continual learning in medical devices: FDA's action plan and beyond

Vokinger, K. N., Feuerriegel, S., & Kesselheim, A. S. (2021) · The Lancet Digital Health

Healthcare RegulationArtificial Intelligence in Healthcare and Education

Cited by 95

New “21st Century Cures” Legislation: Speed and Ease vs Science

Kesselheim, A. S., & Avorn, J. (2017) · JAMA

Pharmaceutical Economics and PolicyBiomedical Ethics and Regulation

Cited by 93

Patents and regulatory exclusivities on GLP-1 receptor agonists

Alhiary, R., Kesselheim, A. S., Gabriele, S., Beall, R. F., Tu, S. S., & Feldman, W. B. (2023) · JAMA

Pharmaceutical Economics and PolicyIntellectual Property and Patents

Cited by 67

U.S. Food and Drug Administration Precertification Pilot Program for Digital Health Software: Weighing the Benefits and Risks

Lee, T. T., & Kesselheim, A. S. (2018) · Annals of Internal Medicine

Healthcare RegulationMobile Health and mHealth Applications

Cited by 62

The Failure of Solanezumab — How the FDA Saved Taxpayers Billions

Sacks, C. A., Avorn, J., & Kesselheim, A. S. (2017) · New England Journal of Medicine

Biomedical Ethics and RegulationPharmaceutical Economics and Policy

Cited by 55

Repurposing existing drugs for new uses: a cohort study of the frequency of FDA-granted new indication exclusivities since 1997

Sahragardjoonegani, B., Beall, R. F., Kesselheim, A. S., & Hollis, A. (2021) · Journal of Pharmaceutical Policy and Practice

Pharmaceutical Economics and PolicyPharmaceutical industry and healthcare

Cited by 52

A systematic review and meta-analysis of bevacizumab in first-line metastatic breast cancer: lessons for research and regulatory enterprises

Hey, S. P., Gyawali, B., D’Andrea, E., Kanagaraj, M., Franklin, J. M., & Kesselheim, A. S. (2020) · JNCI: Journal of the National Cancer Institute

Breast Cancer Treatment StudiesStatistical Methods in Clinical Trials

Cited by 29

Variations in Use of Diabetes Drugs With Cardiovascular Benefits Among Medicaid Patients

Zhai, M. Z., Avorn, J., Liu, J., & Kesselheim, A. S. (2022) · JAMA Network Open

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 7

Generic Liraglutide — Overlooked but Not Forgotten

Gondi, S., Kesselheim, A. S., & Rome, B. N. (2026) · New England Journal of Medicine

Diabetes Treatment and ManagementPharmaceutical Economics and Policy

Cited by 1